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Abstract-The distributions and extent of processing of four prodynorphin-derived peptides 
(dynorphin A (l-171, dynorphin A (l-81, dynorphin B, and a-neoendorphin) were determined 
in ten regions of the cortex as well as in the striatum of the guinea-pig. There were significant 
differences between concentrations of these peptides in most cortical regions, with a- 
neoendorphin being several times more abundant than the other peptides, and dynorphin A 
(I-17) being present in the least amount. There were significant between-region differences 
in concentration for each peptide, although most regions had concentrations similar to those 
seen in the striatum. Concentrations of each peptide tended to be higher in piriform, 
entorhinal, motor, and auditory cortex than in other cortical regions. The extent of processing 
of prodynorphin varied across cortical regions as well, primarily due to the extent of 
processing to a-neoendorphin. Prodynorphin mRNA levels were not significantly different 
between cortical regions or from the amount observed in the striatum. Although specific 
regional variation exists, it appears that in general prodynorphin is expressed and processed 
in a similar manner in the cortex as in the striatum. 
Introduction brain regions.’ Proenkephalin can be processed to 
The endogenous opioid peptides are produced by 
post-translational processing of one of three propep- 
tides, proenkephalin, pro-opiomelanocortin, or pro- 
dynorphin (prodyn). Each of these precursor 
molecules can undergo tissue-specific post-transla- 
tional processing to produce distinct mixes of active 
peptide products, which are often unique for given 
the opkd active enkephalins, and pro-opio- 
melanocortin to a number of functional peptides 
including P-endorphin. Prodyn contains three major 
functional domains which can produce a variety of 
active ligands (Fig. 1). The neoendorphin (NE) 
domain consists of a-NE, which can be further 
processed to P-NE. The dynorphin (dyn) A domain, 
which is dyn A (l-1 7), can be further processed to 
Date received 3 March 1993 dyn A (l-8). The dyn B domain (leurnorphin) can 
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Fig. 1 Schematic of prodynorphin molecule. The major opioid-active domains of prodyn are shown. a-neoendorphin can be 
fbrther processed to P-neoendorphin, dynorphin A (1-17) to dynorphin A (l-8), and leumorphin to dynorphin B. 
affinities for the different subtypes of opioid recep- 
tors.2,3 Proenkephalin and pro-opiomelanocortin 
both produce peptide products that have activity at 
the p and 6 receptors. Prodyn, however, is a partic- 
ularly rich precursor molecule: in addition to pro- 
ducing ligands active at the p and 6 sites, this 
propeptide can also produce peptides with relatively 
high affinities for the K receptor. For example, dyn 
A (l-17), dyn B, and a-NE are all active at the K 
receptor, having affinities for the K receptor about 5 
times higher than for the p receptor, and about 20 
times higher than for the 8 receptor. Compared with 
dyn A (l-l 7), however, dyn A (l-8) has a relatively 
higher af8nity for the 6 receptor. Thus, the extent of 
processing of the dyn A domain partially determines 
the relative 6 vs K functional activity of this domain 
ofprodyn. The combination of abundance and extent 
of processing of prodyn in any given brain region 
thus contributes to the specific overall opioid tone 
in that region. 
Prodyn as well as K receptors are fairly wide- 
spread in the mammalian brain.2,4J+13 The striatum, 
substantia nigra, hippocampus, amygdala, and 
hypothalamus are particularly enriched in these 
molecules. The characterization of brain prodyn has 
concentrated on deep brain structures; the nigro- 
striatal system has been particularly well-character- 
ized.l”16 The striatum contains numerous prodyn- 
synthesizing cells, which project to the substantia 
nigra. In this system in the rat, relatively high 
levels of prodyn are found, and the dyn A domain is 
found primarily expressed as dyn A( l-8) 
The cortex of most species has also been demon- 
strated to contain relatively high levels of both K 
receptor binding as well as prodyn-containing neu- 
rons.17Js While the nigrostriatal system has been 
fairly well-characterized, however, little is known 
concerning the prodyn found in the cortex. Although 
past studies have shown that prodyn-derived prod- 
ucts as well as mRNA can be found in much of the 
cortex, a systematic study of the extent of distribu- 
tion and processing of dyn has not been reported. 
Does the cortex handle prodyn in a manner similar 
to the nigrostriatal system, or is either the synthesis 
or post-translational processing different? Is prodyn 
distributed and processed the same in all of cortex, 
or do certain regions express and/or process this 
propeptide uniquely? The purpose of the current 
study was to determine the distribution of prodyn 
mRNA and peptides, as well as the extent of post- 
translational processing, in multiple cortical regions 
of the rodent, and to compare these data with that 
found in the striatum. We have selected the guinea- 
pig for this study, as this animal has been reported 
to have a higher density of K receptors in the cortex 
relative to other rodent species,Lo~19~20 thus potentially 
reflecting relatively abundant prodyn expression as 
well. 
Materials and methods 
Tissue preparation 
Six adult male Hartley guinea-pigs weighing 
between 300-350 g were sacrificed by rapid decap- 
itation, and their brains were immediately removed 
and placed on wet ice. The brains were sliced in the 
coronal plane and punches were taken from ten cor- 
tical areas (Table 1) as well as from the caudate- 
putamen (CPU). These punches were stored at -8O’C 
until they were extracted. 
Tissue extraction 
Each frozen tissue sample was weighed and 
extracted simultaneously for peptides and mRNA 
using a guanidine isothiocyanate/LiCl extraction 
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Table 1 Cortical regions studied 
Region Corresponding Function 
studied cortical areas* or common name 
Fr Frl, Fr2, Fr3 motor 
Em Ent entorhinal 
Te Tel, Te3 primary auditory 
Cg Cgl, Cg2 anterior cingulate (prefrontal) 
AI AI, Te2 insular cortexlauditoty association 
Par1 Parl, FL, HL primary somatosensory 
Par2 Par2 secondary somatosensoty 
Pir Pir pirifoml 
RSG RSA, RSG retrosplenial (posterior cingulate) 
oc Oc l,Oc2L, Oc2M visual 
*Corresponding areas are approximate cytoarchitecyural regions 
contained in each punch using the descriptive nomenclature of 
Zillesz3 
procedure.21 The supernatant from the initial pre- 
cipitation (peptide phase) was acidified with acetic 
acid, and applied to Sep Pak CU cartridges, washed 
with 0.1% trifluoroacetic acid (TFA), and eluted 
with 60% acetonitile in 0.1% TFA. The eluant was 
dried by rotary evaporation, and the pellet was resus- 
pended in methanol: O.lN HCl (50 : 50, v: v) for 
radioimmunoassay. The mRNA fraction was puri- 
fied and ethanol-precipitated, and resuspended in 
water for Northern analysis. 
Peptide assays 
Previously standardized radioimmunoassays’6~22 
were performed on the peptide extracts using anti- 
bodies specific for the opioid-active peptides dyn A 
(l-17), dyn A (l-8), dyn B, and a-NE, using 1251- 
labeled tracers. The dyn A (1-17) antiserum is 
directed against the C-terminus of this peptide. The 
ICSO ofthis assay is approximately 10 fmol/tube. This 
antiserum has less than 0.00 1% cross-reactivity with 
dyn A (l-8), leucine-enkephalin, or or-NE. The dyn 
A (l-8) antiserum is directed against the C-termi- 
nal region of this molecule, and the IGo of this assay 
is approximately 6 fmol/tube. This antiserum has 
less than 0.00 1% cross-reactivity with dyn A (l-l 7), 
dyn B or leucine-enkephalin, and less than 0.01% 
cross-reactivity with a-NE. The dyn B antiserum is 
approximately 0.002% cross-reactive with dyn A 
(l-8), less than 0.001% cross-reactive with dyn A 
(1-17) or a-NE, and has an IGO of approximately 
15 fmol/tube. The a-NE antiserum is C-terminus 
directed, has less than 0.001% cross-reactivity with 
dyn A (l-8), dyn A (l-17), dyn B, and leucine- 
enkephalin, and has an IGO of 80 fmol/tube. Each 
sample was assayed in triplicate, and the means from 
three different assays were used for subsequent data 
analysis. 
Northern analysis 
RNA samples were chromatographed overnight on 
1% agarose/5% formamide gels; 5 pg of total RNA 
from each region was loaded on the gels. The next 
day, RNA bands were transferred to Nytran mem- 
branes by blotting. The membranes were subse- 
quently probed with a [32P]-labelled 733 base 
riboprobe to rat prodyn. The membranes were then 
briefly shaken in 0.1 x SSC (300 mM NaCl, 30 mM 
sodium citrate, pH 7.2), 0.1% NaDodS04, 1 mM 
EDTA, then washed in 1.5L of the same solution at 
70°C for 2 h. The membranes were apposed to 
Kodak X-OMAT film for several weeks at -80°C. 
Following film development, the resulting bands 
were analyzed by quantitative densitometry. 
Data analysis 
Mean values were obtained for individual peptide 
concentrations in each brain region. A single value 
for mRNA (expressed in units of optical density 
from densitometric analysis) was obtained for each 
region as well. To estimate the extent of interdomain 
processing of prodyn, the ratios of a-NEldyn A, a- 
NE/dyn B, and dyn A/dyn B were calculated. Total 
dyn A was calculated as the sum of dyn A (1-17) 
and dyn A ( l-8). The ratio dyn A ( 1 - 17)ldyn A ( l-8) 
was also calculated as an estimate of intradomain 
processing for the dyn A region; as these two pep- 
tides have different affinities for the opiate recep- 
tors, differences in the processing of the ‘A’ domain 
may be physiologically relevant. All data were ana- 
lyzed by one-way analysis of variance with post-hoc 
comparisons by Dunnett’s t-test, with p < 0.05 used 
to defme significant results. 
Results 
Peptide content 
Dyn A (1-17) levels were significantly different 
across the studied regions (Fig. 2). Levels of this 
peptide tended to be higher in piriform (Pir), entorhi- 
nal (Ent), and primary auditory (Te) cortices than in 
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Fig. 2 Concentrations of prodynorphin-derived peptides in cortical regions and in the striatum (CPU). For each of the four peptides, 
there were significant regional differences in concentration. For dynorphin A (l-17), there were significant differences for region (F 
= 4.88, p < 0.0001). Significant post-hoc comparisons were: Pir > all other cortical regions, but equal to Ent; Ent > all cortical regions 
except Fr, Te, and Pir; Te > Par1 and Cg. Only Pir and Ent were significantly different from CPU. For dynorphin A (l-8) there were 
also significant regional differences (F = 6.13, p < 0.0001). Significant post-hoc comparisons were: Pir > all other cortical regions 
except Ent; Ent > all cortical regions except Pir, Fr, Te; Te > all cortical regions except Ent, Pir, Par1 , Cg, RSG; and Fr > Par 1, Cg, 
RSG, OC. As with dynorphin A (l-17), only Pir and Ent were significantly different from CPU. Dynotphin B also exhibited a main 
effect for region (F = 4.83, p < 0.0001). Post-hoc comparisons revealed Pir > all other cortical regions; and Fr > all cortical regions 
except Ent and Te. Only Pir significantly differed from CPU. Finally, a-neoendorphin concentrations differed across regions (F = 
2.13, p < 0.05). Post-hoc comparisons indicated Pir > all other cortical regions except Ent and Te; and Ent > Par2. Only Pir > CPU; 
all other cortical regions were not significantly different from CPU. For abbreviations used. see Table 1. 
other cortical regions. Both piriform and entorhinal 
cortices had significantly higher levels of dyn (A 
(1-17) than the striatum (CPU), but other cortical 
regions had levels of this peptide similar to those 
measured in the striatum. 
Dyn A (1-8) had a very similar pattern of distri- 
bution to dyn A (l-l 7), and also showed similar sig- 
nificant differences between cortical regions (Fig. 
2). Piriform, entorhinal, and primary auditory cor- 
tices tended to be higher than other cortical areas, 
and the motor area (Fr) had a higher concentration 
than several other regions. As was found for dyn A 
(l-l 7), the levels of dyn A (l-8) in the piriform and 
entorhinal cortices were significantly elevated over 
the level found in the striatum. 
Dyn B and o-NE levels also both differed signif- 
icantly between regions (Fig. 2). The highest levels 
of dyn B were found in the piriform and motor cor- 
tices, and the highest levels of a-NE in piriform and 
entorhinal cortices. Of all cortical regions, only the 
piriform cortex had significantly higher dyn B and 
a-NE levels than the striatum. 
Examination of the relative contribution of each of 
the four prodyn-derived peptides to the total amount 
of peptide measured revealed that the greatest con- 
tribution in every region studied came from a-NE 
(Fig. 3). The next most abundant domain in all regions 
was dyn A, which was predominantly expressed as 
dyn A (l-8). Those regions which consistently had 
the highest individual peptide levels (piriform, 
entorhinal, primary auditory and motor areas), had 
the smallest relative contribution from a-NE. 
PRODYNORPHIN-DERIVED PEPTIDES AND mRNA IN GUINEA-PIG CORTEX 135 
1.00 
l m 
0.1s : E,,, 1 0 AU-13 
1 0.50 
f 0.2s 
Fig. 3 Relative contribution of each of the four prodynorphin- 
derived peptides to total prodynorpbin expression. Note that cz- 
neoendorphin is the most abundant fotm in each region of cortex 
as well as in the striatum (CPU). The dynorphin A domain is the 
next most abundant, comprised in large part of dynorphin A (l-8). 
In general, the relative contributions of each peptide in the cor- 
tical regions is quite similar to what is observed in the shiatum. 
Messenger RNA levels 
To examine the possible effects of transcription on 
the regional variation observed in peptide con- 
centrations and processing, mRNA levels were 
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Peptide processing 
To estimate the extent of the processing of prodyn 
within different cortical regions, ratios of peptide 
concentrations were calculated for each region. Both 
between-domain processing (Fig. 4) and within- 
domain processing (of the ‘A’ domain, Fig. 5) com- 
parisons were made. 
The ratio a-NEldyn B was uniformly greater 
than one, and ranged from 5-18 (Fig. 4). There 
were significant regional differences in this ratio. 
In general, this ratio was significantly lower in pri- 
mary auditory, piriform and motor cortices than in 
other cortical regions. This ratio was significantly 
lower in piriform and motor cortex than in the stria- 
turn, but did not differ from the striatum in other 
cortical regions. The ratio ol-NE/dyn A was sig- 
nificantly different across regions as well, with 
higher values in primary somatosensory (Par l), 
visual (OC), and retrosplenial (RSG) cortices than 
in other cortical regions. All cortical regions had a 
similar value of this ratio compared to the striatum, 
except for primary somatosensory and retrosple- 
nial cortices, in which this ratio was higher than in 
the striatum. The ratio dyn A/dyn B was not sig- 
nificantly different between the cortical regions or 
the striatum. 
Within-domain processing was estimated for the 
‘A’ domain of prodyn (Fig. 5), by determining the 
ratio of dyn A (I-17)/dyn A(l-8). No significant 
differences were found either between cortical 
regions or between any region and the striatum. 
0 
Bm Te Cg Al Pb Rso oc 
Fig. 4 Between-domain processing of prodynorphin. The ratios 
of each domain to each of the other two are demonstrated as an 
estimate of the extent of between-domain processing of pro- 
dynorphin. Regional differences were found for the ratio a-neoen- 
dorphmdynorphin B (F = 3.30, p < 0.005). Significant post-hoc 
comparisons included: Te, Pir, and Fr < Par 1, RSG, OC, and AI; 
and Fr < Par2. The CPU was only significantly different from Fr 
and Pir, and similar to all other cortical regions. Similarly, the ratio 
of c+neoendorphin/dynorphin A was significantly different across 
regions (F = 4.97, p < 0.0001). Significant post-hoc comparisons 
included: Parl, RSG, OC > Fr, Ent, Te, Pir; Par1 > Par2 and Cg; 
and RSG > AI > Fr. Only Par1 and RSG were significantly dif- 
ferent from CPU. Although there were significant regional differ- 
ences in the ratios containing a-neoendorphin, the ratio of 
dynorphinA/dynorphinB wasnotsignificantlydifferent(F=0.71) 
across regions. Note that these ratios in cortex are very similar to 
those in the striatum (CPU) in each case. 
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Fig. 5 Ratio of dynorphin A (1-17)idynoqhin A (l-8). This 
ratio is presented as an estimate of within-domain processing for 
the ‘A’ domain. This ratio was not significantly different (F = 
0.67) between cortical regions nor from that seen in the striatum. 
Table 2, there were no statistically significant dif- 
ferences between cortical regions or between any 
region and the striatnm (F = 1.33, p = n.s.>. 
Discussion 
This study was designed to examine prodyn expres- 
sion and processing in the cortex of the guinea-pig, 
and to compare these findings with those seen in the 
more well-understood striatum. For the most part, 
the cortex and the striatum appear to handle prodyn 
in a similar manner, at the levels of mRNA expres- 
sion, peptide content, and apparent extent of post- 
translational processing. Some regional variation in 
peptide levels and extent of processing were found, 
however, with a few cortical regions having consis- 
Table 2 Prodynorphin mRNA content in ten cortical 
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183 f 30 
276 f 28 
204 f 13 
169 f 42 
262 f 32 
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262 f 37 
96 k 55 
Values are expressed as mean f SEM in units of optical density. 
There were no significant differences between the individual 
regions. 
tently higher peptide levels, and several regions 
having relatively less contribution to total peptide 
levels from a-NE, than other cortical regions and 
the striatum. 
As has been previously demonstrated in the rodent 
nigrostriatal system, I6 levels of a-NE were consid- 
erably higher than levels of any of the products 
derived from the A & B domains of prodyn in all 
regions studied. The structure of prodyn suggests 
that the three domains might be expected to be pre- 
sent in equal concentrations, yet a-NE was consis- 
tently higher. Trujillo et alI6 suggested that this 
phenomenon might be due to the primary amino acid 
sequence of the prodyn molecule. Each functional 
domain contains leucine enkephalin as a theoretical 
product. In both the dyn A & B domains, the cleav- 
age site for the liberation of enkephalin is the diba- 
sic amino acid pair, arginine-arginine. In the 
neoendorphin domain, however, this cleavage site 
is arginine-lysine. The discrepancy in content that 
has been previously reported and observed in this 
study may reflect the differential preference of 
endogenous processing enzymes for these dibasic 
cleavage sites. This would suggest that arginine- 
arginine is more favored for enzyme action than 
arginine-lysine; accordingly, the prodyn A & B 
domains may be further processed to leucine 
enkephalin, while the neoendorphin domain may not 
be favored for continued processing to enkephalin. 
This scenario would result in an apparent accumu- 
lation of neoendorphin products relative to longer 
peptide fragments derivied from the A & B domains. 
Whatever the mechanism, however, it appears that 
the cortex processes the dynorphin precursor in a 
manner similar to the striatnm. 
After a-NE, the most abundant domain was dyn 
A. Dyn A exists as dyn A (l-17), or can be further 
processed to dyn A (1-g). Dyn A (1-S) was found 
in higher concentrations than dyn A (l-l 7), which 
suggests a relatively greater 6 versus K opioid tone 
associated with the A domain in the cortex. Further, 
the cortex appears to process the A domain much 
like the striatum. 
Despite the similarity of prodyn expression 
within the cortex and between cortical regions and 
the striatum, there were several significant differ- 
ences. Four regions of cortex (piriform, entorhinal, 
primary auditory and motor areas), tended to have 
higher peptide levels than other regions. Of these 
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four areas, the piriform and entorhinal were the 
highest, and were the only areas to consistently have 
levels significantly higher than the stiatum. Both 
the piriform and entorhinal regions are associated 
with limbic integration functions, and this consis- 
tent elevation of peptide levels may be associated 
with this functional role of these regions. It is not 
clear, however, why primary auditory and motor 
areas might also have increased peptide levels; 
these differences will need to be the subject of future 
investigation. 
In comparing peptide ratios to explore possible 
differences in apparent peptide processing, there 
was again similarity seen between the cortex and 
striatum. While the a-NEldyn A and a-NEldyn B 
ratios showed some variability, the dyn A/dyn B, 
and dyn A (l-l 7)/dyn A( l-8) were remarkably sim- 
ilar throughout cortex and striatum. Processing dif- 
ferences appeared to be related to the extent of 
expression of the neoendorphin domain: in those 
regions with the highest total peptide levels, the rel- 
ative contribution from a-NE was the lowest, hence 
the ratios containing a-NE were lower in those spe- 
cific regions. One possible explanation forthis is that 
processing enzymes that convert dyn A and dyn B 
into leucine enkephalin may be substrate saturated 
or otherwise less active in those regions of cortex 
with higher total dyn content. 
To determine at what level of prodyn gene regu- 
lation the observed content and processing differ- 
ences might occur, prodyn mRNA levels were also 
determined in the same regions. There were no sig- 
nificant differences in prodyn mRNA between cor- 
tical regions or between the cortex and the striatum. 
These data suggest that the variability found in pep- 
tide expression is not transcriptionally mediated, but 
is rather determined at the level of translation or 
post-translational processing. 
These results indicate that with the exception of 
a few cortical areas, prodyn is handled quite simi- 
larly in the cortex and the striatum of the guinea-pig. 
There were a few regional differences found, with 
increased peptide levels being present in limbic, 
auditory, and motor cortical regions, but the signif- 
icance of this remains unclear. In general, however, 
it appears that dynorphin may serve a general rather 
than a region-specific function throughout much of 
the cortex. 
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